• Image of Nipah virus

    Study Proposes a Live Attenuated SARS-CoV-2 Vaccine Candidate

    In a new study published recently on Nature Communications, researchers engineered a live-attenuated SARS-CoV-2 vaccine candidate that could potentially be studied at biosafety level 2 for easier COVID-19 research and countermeasure development.

  • Texas researchers develop COVID nasal vaccine

    The Austin television station reported researchers at UTMB developed a COVID-19 vaccine delivered through the nose. It can add extra protection against COVID-19 since it can “effectively” kill the virus where it enters the body— the respiratory tract. The vaccine can be delivered in a nasal spray. Researchers found the new vaccine is stable, but they need to do further animal and human trials. “These efforts are underway and crucial since more than 10 billion doses of vaccines are needed across the globe, particularly in middle- to low-income countries, where the affordability of the current vaccines is a big concern,” said Dr. Ashok Chopra, UTMB microbiologist and co-author of the study. World Pharma News reported this news as well, and i45now interviewed Dr. Chopra about this second-generation vaccine.

  • COVID-19-Related Stress, Isolation Negatively Impacts Adolescents

    Dr. Jeff R. Temple, from the University of Texas Medical Branch Health at Galveston, and colleagues assessed whether COVID-19-induced financial impact, stress, loneliness, and isolation were related to perceived changes in adolescent mental health and substance use. Dr. Temple also appeared on KHOU’s Sunday morning news program July 24 to discuss this research.

  • How climate change is 'creating' a new era of infectious disease danger

    Scott Weaver, director of science at Galveston National Laboratory, told The Paper that he believes a Nature study more formally confirms what many virologists intuitively suspected: that climate change will redistribute many habitats for zoonotic virus hosts, promoting the risk of virus cross-species transmission. In addition, the concentration of less diverse animal populations in smaller areas may facilitate zoonotic outbreaks, which would increase the risk of epidemics spreading to humans. However, Weaver also said that it is difficult to pinpoint climate change as “conclusive evidence” of known cross-species shifts, as several other important factors are involved, such as deforestation and land use. “We need better monitoring of viruses and their hosts to identify projected changes in virus distribution before we can directly determine the direct impact of climate change on humans,” he said.

  • County keeps tabs on monkeypox

    The Brazoria County newspaper reported that the U.S. cases of monkeypox appear to be transmitted more along sexual network pathways, quoting UTMB Biocontainment Care Unit Medical Director Dr. Susan L.F. McLellan. “That is one way it can be transmitted and the most common in the current outbreak,” she said. “It can be transmitted through other means, such as skin-to-skin between people who have contact with someone with a lesion and someone without. It is commonly spread through networks where individuals are having high-frequency sexual encounters with new partners.” Dr. McLellan also joined the July 26 Town Square program on Houston Public Media to answer questions about monkeypox.

  • Renowned Galveston native George Sealy dies at 95

    George Sealy, an island native from one of Galveston’s most distinguished families and a longtime member of the Sealy & Smith Foundation board, died July 23. “George Sealy will long be remembered for his visionary advocacy and support for UTMB’s mission,” said Dr. Ben Raimer, medical branch president. “And, for everyone who was fortunate enough to meet him personally, George’s wisdom and legendary sense of humor will be greatly missed.”

  • Eggs got a bum rap and other medical news you can use

    “Of the thousands of medical articles published annually, of most interest to those of us in primary care are the ones that have an impact on how we practice,” wrote Dr. Victor S. Sierpina in his column. “These are the studies that show how to improve patient outcomes in morbidity and mortality, reduce risk, improve safety and lower costs.” And he lists some top studies.

  • Scientists develop second-generation COVID-19 vaccine taken nasally

    As scientists race to create the next generation of COVID-19 vaccines, this UTMB/CUA research in mice adds new possibilities for fighting the disease in humans in the future. Nasal vaccination induces another type of an immune response which can effectively kill the pathogen at the port of entry, which is the respiratory tract for SARS-CoV-2. No injections are needed, and the vaccine can be delivered in a nasal spray.

  • A profile of a person's face made of jigsaw puzzle pieces with a lightbulb above it and math formulas written in the background.

    Innovation meets entrepreneurship at UTMB

    This summer, the University of Texas Medical Branch and Texas A&M Galveston are teaming up to help students in the field of life sciences propel the good ideas rattling around in their heads into creative solutions that make a real difference in people’s lives.

  • BA.5 COVID symptoms doctors are seeing the most right now

    The current COVID-19 variants are more transmissible than ever, leading to a higher rate of infection throughout the country and increased risk associated with most activities. “The current variants, which are BA.4 and BA.5, constitute for about 82% of our current variants within our health system,” Dr. Janak Patel, director of the Division of Infectious Disease and Immunology at the University of Texas Medical Branch, told HuffPost.

Categories